Healthy Aging: Helminths as a New Lead
Living longer matters less than living longer in good health, and the chronic low-grade inflammation of aging (inflammaging) is a major obstacle. Two recent studies show that type 2 immunity, which helminths trigger naturally, acts all the way into the bone marrow. Fagnan et al. (Nature, 2026) describe in mice an emergency type 2 myelopoiesis, triggered by IL-33 through the LMO4-GATA2 axis, which steers progenitors toward basophils, eosinophils and mast cells. Yao et al. (Immunity, 2026) show that IL-4 restores lymphocyte production and improves the performance of aged mice. Together these results suggest that a helminth could sustain an endogenous brake on inflammaging. A 2018 experiment in CBA mice, in which early inoculation with Heligmosomoides polygyrus shortened lifespan, seems to contradict this hypothesis. This review explains why it did not test it (a strain with a weak type 2 response, a single inoculation), proposes better-designed preclinical studies (regular re-inoculations, responder strains, normal microbiota, models closer to Necator americanus) and discusses dosing schedules for helminthic therapy clinical trials.French version: https://doi.org/10.5281/zenodo.24202673
Authors
- Jacques Le Marois
Publication Details
- Journal
- Zenodo (CERN European Organization for Nuclear Research)
- Published
- 2026-11-13
- DOI
- https://doi.org/10.5281/zenodo.24202671
- Primary Topic
- Parasites and Host Interactions
- Type
- preprint